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Primary lymphomas of the breast are very rare breast malignancies with an incidence rate of 0.12–0.5% and 2.2% of extranodal lymphomas [1,2]. Majority of the 
breast lymphomas are the non-Hodgkin’s type, representing 
approximately 70–90% [3]. Diffuse large B-cell lymphomas 
(DLBCL) mainly form the bulk of about 46–71% of all primary 
breast lymphomas [4]. There are still studies going on to reveal 
the pathogenesis of breast lymphomas. Prognostic factors 
include clinical staging, histological type, and patient’s age. 
Diagnosis is mostly by routine fine-needle aspiration cytology 
(FNAC) performed for breast lumps, but sometimes it can lead to 
misdiagnosis as poorly differentiated duct carcinoma.
T-cell rich BCL (TCRBCL) is a recently described histologic 
variant of BCL characterized by a minor population of clonal B cells 
distributed in a background of numerically preponderant polyclonal 
T lymphocytes. While precise histologic criteria have not yet been 
defined, clonal B cells typically comprise 10% or less of the total 
cellular constituency [5]. Controversy persists with regard to both 
the clinical relevance and the proper classification of this histologic 
variant. The latter is largely a semantic issue, provided these cases are 
distinguished from both peripheral T-cell lymphoma and Hodgkin’s 
disease, with which they may be easily confused. We report the case 
of a TCRBCL of the breast in a premenopausal woman.
CASE REPORT
A 41-year-old African woman presented in our multi-specialty 
cancer hospital in February 2016 with the history of a non-tender 
lump in the left upper outer quadrant of the breast for re-evaluation. 
She had the breast lump since October 2014 for which she was 
evaluated with Biopsy in February 2015 and was diagnosed 
as T-cell non-Hodgkin lymphoma in her native place. She had 
received 6 cycles of cyclophosphamide, doxorubicin, Oncovin, 
and prednisolone chemotherapy in her country after which the 
scan in July 2015 showed stable disease. In our hospital, the 
patient presented for re-evaluation of the breast with the history 
as mentioned above. There was no history of nipple discharge, 
fever, bone pain, or respiratory discomfort. There was no history 
of cancer breast as well as lymphoma in the family.
The patient was clinically stable with negative serology. 
Clinical examination revealed a rubbery, non-tender, ill-defined, 
and mobile lump in the axillary tail of the left breast of size 
about 3 cm × 4 cm with normal overlying skin. There was no 
retraction of or discharge from the nipple. Ipsilateral axilla had 
multiple, enlarged, firm and fixed lymph nodes. Opposite breast 
and axilla were unremarkable. There was no other significant 
lymphadenopathy. Per abdominal examination was normal.
Bilateral mammography showed multiple ill-defined 
nodular opacities in the left axillary tail, and corresponding 
sonomammography revealed multiple enlarged left axillary 
lymph nodes with distorted architecture, likely metastatic. 
Positron emission tomography-computed tomography scan 
revealed bulky metabolically active left axillary, left deep pectoral 
and left internal mammary, and portocaval interval lymph nodes. 
Metabolically active subcutaneous soft tissue lesion in the left 
lower axilla, mild splenomegaly with multiple metabolically 
active focal lesions and the small metabolically active focal lesion 
in the right posterior iliac bone as depicted in Fig. 1.
Biopsy of the breast lump and lymph node was done which 
revealed TCRBCL of the breast. On immunohistochemistry (IHC), 
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the large neoplastic lymphoid cells expressing CD-20, CD-30 
(focal and weak), Oct-2, and BoB-1 (focal and weak), negative for 
CD-79a and EMA, and background cells richly positive for CD-3, 
CD-23, and Ki-67 index 60% in T-cells were found as depicted 
in Fig. 2. Bone marrow aspiration and biopsy were done, which 
showed hypercellular marrow with trilineage hematopoiesis with 
no definite evidence of lymphomatous involvement in the aspirate.
On these investigations, we came to a diagnosis of T-cell 
rich B-cell non-Hodgkin lymphoma Stage IV of the left breast 
with a low international prognostic index score. She was planned 
for 3 cycles of 2nd line chemotherapy with Rituxan, Ifosfamide, 
Carboplatin, Etoposide regimen followed by a bone marrow 
transplant. The patient had a good response after the treatment. At 
present, the patient is under follow-up.
DISCUSSION
Non-Hodgkin’s lymphoma especially TCRBCL involving the 
breast as a primary site or as a secondary site is a very rare 
malignancy. T-cell/histiocyte-rich BCL (T/HRBCL) is a very 
uncommon morphologic variant of DLBCL. Pathologically, it 
is distinguished by <10% malignant B-cells along with majority 
population of reactive T lymphocytes/histiocytes. Diagnosis of 
this entity is usually difficult, as it may appear similar to other 
lymphoid diseases, such as nodular lymphocyte-predominant 
Hodgkin’s lymphoma and classic Hodgkin’s lymphoma.
The incidence of clonal B-cell neoplasms with reactive T 
lymphocytes infiltrates was first recognized by Jaffe et al. [6] in 
a report of “pseudo-peripheral T-cell lymphoma.” Mirchandani 
et al. [7] also reported a series of similar cases in his study. The 
term T-cell-rich BCL was discovered by Ramsay et al. [8] who 
described five BCL in which clonal B cells comprise <10% of 
lymphoid cells. The clinical significance of the preponderant 
T-cell response that characterizes these lymphomas is uncertain. 
Various authors have described a host-immune response to the 
neoplastic clone, analogous to that seen in Hodgkin’s disease [9].
Scarpa et al. [10] made an observation in his study that 
the T-cell reaction tends to diminish as the disease progresses 
and escapes immune surveillance. Besides, it could also 
represent a response of the reactive T-cells to some cytokine 
secreted by the tumor cells. Accurate diagnosis requires careful 
immunohistochemical analysis of the tumor cells and the 
inflammatory microenvironment. IHC forms the main test to 
diagnose this rare lymphoma which could have been missed or 
misdiagnosed. It helps to differentiate properly from simple T-cell 
lymphoma due to the presence of markers. Like other DLBCLs, 
Figure 2: Histopathology T-cell rich B-cell lymphomas showing 
monomorphic lymphoid cells with large scattered cells
Figure 1: Positron emission tomography-computed tomography scan whole body showing breast lesion before after treatment
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TCRBCLs follow an aggressive clinical course. It progresses 
very rapidly; the relapse rate is also very high. In case, if it is not 
treated with multidisciplinary modalities, recurrence is high with 
poor prognosis.
CONCLUSION
Core biopsy with IHC is essential to diagnose T-cell rich B-cell 
non-Hodgkin lymphoma of the breast which is more conclusive 
than FNAC and helps in the accurate management of treatment 
that is different from the ductal breast cancers as well as other 
lymphomas.
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